Skin Laboratory PCL (BKK:SKIN)
Thailand · Delayed Price · Currency is THB 1.010
+0.120 (13.48%)
At close: Sep 14, 2026
Skin Laboratory PCL Ratios and Metrics
Market cap in millions THB. Fiscal year is January - December.
Millions THB. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 11, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 128 | 194 | - | - | - | - | |
Market Cap Growth | - | - | - | - | - | - |
Enterprise Value | 66 | 116 | - | - | - | - |
Last Close Price | 0.89 | 1.35 | - | - | - | - |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 11, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | - | 44.41 | - | - | - | - |
PS Ratio | 0.85 | 1.09 | - | - | - | - |
PB Ratio | 1.48 | 1.92 | - | - | - | - |
P/TBV Ratio | 1.49 | 1.93 | - | - | - | - |
P/FCF Ratio | - | 16.24 | - | - | - | - |
P/OCF Ratio | - | 15.60 | - | - | - | - |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 11, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 0.44 | 0.65 | - | - | - | - |
EV/EBITDA Ratio | - | 18.78 | - | - | - | - |
EV/EBIT Ratio | - | 20.27 | - | - | - | - |
EV/FCF Ratio | - | 9.73 | - | - | - | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 11, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.01 | 0.01 | 0.04 | 0.06 | 0.05 | 0.03 |
Debt / EBITDA Ratio | - | 0.19 | 0.17 | 0.20 | 0.22 | 0.07 |
Debt / FCF Ratio | - | 0.12 | 0.75 | 0.17 | 0.77 | 0.25 |
Net Debt / Equity Ratio | -0.71 | -0.75 | -0.44 | -0.63 | -0.48 | -0.54 |
Net Debt / EBITDA Ratio | 3.36 | -12.30 | -1.88 | -2.09 | -2.21 | -1.14 |
Net Debt / FCF Ratio | 3.19 | -6.38 | -7.59 | -1.72 | -7.46 | -3.88 |
Asset Turnover | 1.62 | 1.72 | 2.43 | 2.64 | 2.76 | 1.89 |
Inventory Turnover | 2.06 | 2.57 | 3.05 | 3.08 | 2.79 | 3.01 |
Quick Ratio | 5.85 | 5.10 | 2.91 | 2.74 | 2.71 | 3.15 |
Current Ratio | 7.68 | 6.15 | 3.91 | 3.42 | 3.58 | 4.46 |
Return on Equity (ROE) | -24.29% | 5.38% | 15.95% | 23.37% | 15.83% | 40.76% |
Return on Assets (ROA) | -12.22% | 3.44% | 8.90% | 12.88% | 9.26% | 21.79% |
Return on Invested Capital (ROIC) | -76.25% | 15.13% | 34.65% | 52.98% | 32.78% | 107.54% |
Return on Capital Employed (ROCE) | -20.20% | 5.50% | 20.60% | 27.70% | 20.10% | 44.90% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 11, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | -14.01% | 2.25% | - | - | - | - |
FCF Yield | -15.09% | 6.16% | - | - | - | - |
Payout Ratio | - | 376.89% | 656.07% | 95.31% | 110.21% | 46.92% |
Buyback Yield / Dilution | -46.42% | -162.19% | -2048.36% | - | - | - |
Total Shareholder Return | -46.42% | -162.19% | -2048.36% | - | - | - |